Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/23547
Title: Validation of Exercise Capacity as a Surrogate Endpoint in Exercise-Based Rehabilitation for Heart Failure: A Meta-Analysis of Randomized Controlled Trials
Contributor(s): Ciani, Oriana (author); Piepoli, Massimo (author); Smart, Neil  (author)orcid ; Uddin, Jamal (author); Walker, Sarah (author); Warren, Fiona C (author); Zwisler, Ann D (author); Davos, Constantinos H (author); Taylor, Rod S (author)
Publication Date: 2018
Open Access: Yes
DOI: 10.1016/j.jchf.2018.03.017Open Access Link
Handle Link: https://hdl.handle.net/1959.11/23547
Abstract: OBJECTIVES This study sought to validate exercise capacity (EC) as a surrogate for mortality, hospitalization, and health-related quality of life (HRQOL). BACKGROUND EC is often used as a primary outcome in exercise-based cardiac rehabilitation (CR) trials of heart failure (HF) via direct cardiorespiratory assessment of maximum oxygen uptake (Vo₂peak) or through submaximal tests, such as the 6-min walk test (6MWT). METHODS After a systematic review, 31 randomized trials of exercise-based CR compared with no exercise control (4,784 HF patients) were included. Outcomes were pooled using random effects meta-analyses, and inverse variance weighted linear regression equations were fitted to estimate the relationship between the CR on EC and all-cause mortality, hospitalization, and HRQOL. Spearman correlation coefficient (r), R2 at trial level, and surrogate threshold effect (STE) were calculated. STE represents the intercept of the prediction band of the regression line with null effect on the final outcome. RESULTS Exercise-based CR is associated with positive effects on EC measured through Vo₂peak (þ3.10 ml/kg/min; 95% confidence interval [CI]: 2.01 to 4.20) or 6MWT (þ41.15 m; 95% CI: 16.68 to 65.63) compared to control. The analyses showed a low level of association between improvements in EC (Vo₂peak or 6MWT) and mortality and hospitalization. Moderate levels of correlation between EC with HRQOL were seen (e.g., R2 <52%; jrj < 0.72). Estimated STE was an increase of 5 ml/kg/min for Vo₂peak and 80 m for 6MWT to predict a significant improvement in HRQOL. CONCLUSIONS The study results indicate that EC is a poor surrogate endpoint for mortality and hospitalization but has moderate validity as a surrogate for HRQOL. Further research is needed to confirm these findings across other HF interventions.
Publication Type: Journal Article
Source of Publication: JACC: Heart Failure, 6(7), p. 596-604
Publisher: Elsevier Inc
Place of Publication: United States of America
ISSN: 2213-1779
Field of Research (FOR): 110201 Cardiology (incl. Cardiovascular Diseases)
110602 Exercise Physiology
Peer Reviewed: Yes
HERDC Category Description: C1 Refereed Article in a Scholarly Journal
Appears in Collections:Journal Article
School of Science and Technology

Files in This Item:
3 files
File Description SizeFormat 
Show full item record

SCOPUSTM   
Citations

1
checked on Nov 30, 2018

Page view(s)

144
checked on Feb 8, 2019
Google Media

Google ScholarTM

Check

Altmetric


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.